Federal Register Notice: FDA will hold a public hearing 3/25-26 to obtain input on the Over-the-Counter (OTC) Drug Review (sometimes referred to as the OTC Monograph Process, OTC Monograph, or OTC Drug Review) on how to improve or alter the current process for reviewing nonprescription drugs marketed under the OTC Drug Review. The hearing will be held from 9 a.m. to 4 p.m. at FDA’s White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, Rm. 1503A, Silver Spring, MD. Contact Mary Gross, (301) 796-3519. To view this notice, click here.